XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2
Collaboration, Development and Supply Agreements - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 30, 2021
May 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Oct. 31, 2021
Jan. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Account Receivable     $ 1,972,000   $ 1,972,000   $ 15,600,000    
Revenue recognized     256,464,000 $ 52,767,000 370,456,000 $ 136,102,000      
Accrued liabilities     34,146,000   34,146,000   49,796,000    
CpG 1018                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized     91,300,000   113,600,000        
CEPI Partners [Member] | Reservation Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Increase in interest free unsecured forgiveable loan maximum borrowing capacity   $ 77,400,000              
Interest free unsecured forgiveable loan Maximum borrowing capacity   $ 176,400,000              
Clover                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized       0   0      
Clover | Supply Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue     138,700,000   138,700,000   191,100,000    
Accounts Receivable Net Current     19,200,000   19,200,000   2,100,000    
Contract asset balance     71,300,000   71,300,000   62,500,000    
Medigen | Supply Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized       10,600,000   17,500,000      
Accounts Receivable Net Current             2,400,000    
Valneva SE                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Advance payment from customer               $ 55,400,000  
Consideration Allocated To The Remaining Performance Obligation               $ 55,400,000  
Deferred revenue     55,400,000   55,400,000        
Valneva SE | Supply Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue     0   0   55,400,000    
Revenue recognized     68,000,000.0 24,500,000 68,000,000.0 89,400,000      
Accounts Receivable Net Current     12,600,000   12,600,000   0    
Biological E. Limited | Supply Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue     47,700,000   47,700,000   103,300,000    
Revenue recognized     51,000,000.0   118,300,000        
Accounts Receivable Net Current     95,600,000   95,600,000   96,100,000    
PT Bio Farma (Persero) | Supply Agreement                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue     5,500,000   5,500,000        
Revenue recognized     12,300,000   14,300,000        
Accounts Receivable Net Current     17,900,000   17,900,000        
U.S. Department of Defense                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized     1,100,000   2,700,000        
Proceeds from grant $ 22,000,000.0                
Serum Institute of India Pvt. Ltd.                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized       $ 100,000   $ 300,000      
Serum Institute of India Pvt. Ltd. | Other Revenues                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized     34,326,000   100,000        
CEPI Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Interest- free unsecured forgivable loan                 $ 99,000,000.0
Advance payment from customer     175,100,000   175,100,000        
Long-term deferred revenue             5,400,000    
Account Receivable     0   0   14,600,000    
Accrued liabilities     $ 107,400,000   $ 107,400,000   $ 128,800,000